Ophthalmic Market Perspectives Monthly Newsletter

January, 2024

Market Scope has published the Ophthalmic Market Perspectives (OMP) newsletter for more than 20 years. The newsletter provides the latest business information that is shaping ophthalmic markets and professions. Our articles explore new technologies and company developments. We offer opinions on issues facing the industry. We also analyze and chart quarterly industry data, and we forecast market performance over time.

The OMP provides perspective on products, events, and market trends, and timely information and analysis on the following:

  • US cataract, refractive, glaucoma, and retinal procedure volumes
  • Newly commercialized ophthalmic devices and pharmaceuticals
  • Investigational technologies
  • Economic issues affecting the ophthalmic industry and medical practice
  • Yearly US regulatory updates on cataract, refractive, retinal, glaucoma, and dry eye devices and pharmaceuticals
  • Presentations and developments at major ophthalmic meetings—the AAO, the ASCRS, ARVO, the ESCRS, and other key meetings
  • Previews of significant agenda items at upcoming ophthalmic meetings
  • Trends in the practice of ophthalmic medicine
  • Mergers and acquisitions of ophthalmic companies
  • Previews/summaries of newly published Market Scope comprehensive reports
  • New surgical techniques
  • Controversies affecting the ophthalmic industry
  • Ophthalmic news from Europe, Japan, China, India, and other regions
  • Shifts in the competitive landscape within ophthalmic market segments
  • Retinal, glaucoma, and dry eye pharmaceuticals
  • Briefs on new executive officers and other changes in top personnel
  • And much more

Market Scope’s ophthalmic industry newsletter is meticulously prepared by a dedicated team of in-house writers and analysts. Data points are derived from a combination of sources, including the following:

  • Analysis of published company financial reports;
  • Focused coverage of ophthalmic scientific research and industry news;
  • Participation in major worldwide ophthalmic meetings;
  • Interviews and cultivated relationships with company executives and practitioners.

1 licensing type is available for this subscription:

  • The price of the Yearly single-user license is $1,750.

SINGLE USER LICENSE

  • The Single User License allows for the use of a report by a single user within one corporate location.
  • The report paper copy may not be reproduced (additional paper copies available for purchase).
  • Report PDF copy can not be copied (if purchased) and must remain on one computer (not a company server).
  • Only a single copy of the publication may be printed for internal use.
  • Users may include information in the report in presentations and internal reports by providing full copyright credit to Market Scope.
  • Users may not share the report (or any information contained therein) with any other person or persons outside the corporate location for which the report is purchased.

ENTERPRISE LICENSE

  • The Enterprise License allows for the use of a report by unlimited users within the purchasing organization.
  • Purchasing organization shall have the right to share the report with third parties. (investors, consultants, etc.) from time to time under the global license agreement, provided that such third parties have a confidentiality agreement with the purchasing organization and agree to be bound by the terms of the global license agreement.
  • Employees of the purchasing organization can include information given in the report in presentations and internal reports by providing full copyright credit to Market Scope.
  • Purchase price includes a printable PDF file of the report (purchasing organization may print multiple copies for use within the organization).
  • Purchase price includes a supplemental Excel file containing all the tables and figures included in the purchased report.

Pay by credit card or by invoice.

Want to Purchase the Full Report?

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.